Sarepta Therapeutics (SRPT) PT Raised to $174 at UBS
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $21.03 --0%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 30
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 30
Join SI Premium – FREE
UBS analyst Colin Bristow raised the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $174.00 (from $173.00) while maintaining a Buy rating.
You May Also Be Interested In
- Middleby Corp (MIDD) PT Raised to $160 at Canaccord
- EDP Renovaveis (EDPR:PL) PT Raised to EUR16.80 at Jefferies
- Nexans SA (NEX:FP) (NXPRF) PT Raised to EUR158 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
